MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 63 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,227,218 | +32.5% | 38,836 | +8.5% | 0.00% | – |
| Q2 2023 | $926,198 | +60.0% | 35,802 | +48.6% | 0.00% | – |
| Q1 2023 | $578,882 | +23.2% | 24,100 | 0.0% | 0.00% | – |
| Q4 2022 | $469,950 | +8.5% | 24,100 | +17.0% | 0.00% | – |
| Q3 2022 | $433,000 | +8.0% | 20,600 | 0.0% | 0.00% | – |
| Q2 2022 | $401,000 | -11.7% | 20,600 | 0.0% | 0.00% | – |
| Q1 2022 | $454,000 | +38.0% | 20,600 | 0.0% | 0.00% | – |
| Q4 2021 | $329,000 | -1.2% | 20,600 | +23.4% | 0.00% | – |
| Q3 2021 | $333,000 | +15.2% | 16,700 | 0.0% | 0.00% | – |
| Q2 2021 | $289,000 | -2.0% | 16,700 | +12.1% | 0.00% | – |
| Q1 2021 | $295,000 | +13.5% | 14,900 | 0.0% | 0.00% | – |
| Q4 2020 | $260,000 | +0.8% | 14,900 | +11.2% | 0.00% | – |
| Q3 2020 | $258,000 | -1.1% | 13,400 | 0.0% | 0.00% | – |
| Q2 2020 | $261,000 | -97.7% | 13,400 | -98.8% | 0.00% | -100.0% |
| Q3 2019 | $11,517,000 | – | 1,144,813 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 1,921,118 | $38,269,000 | 6.42% |
| FRAZIER MANAGEMENT LLC | 3,566,912 | $71,053,000 | 5.68% |
| Novo Holdings A/S | 2,445,147 | $48,707,000 | 2.52% |
| Sio Capital Management, LLC | 248,978 | $4,960,000 | 1.58% |
| Mesirow Financial Investment Management, Inc. | 25,795 | $514,000 | 1.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,282,912 | $65,396,000 | 1.28% |
| NEA Management Company, LLC | 4,187,801 | $83,421,000 | 0.99% |
| MPM BioImpact LLC | 308,532 | $6,146,000 | 0.95% |
| Rock Springs Capital Management LP | 1,525,623 | $30,390,000 | 0.64% |
| BVF INC/IL | 435,936 | $8,684,000 | 0.34% |